Price $5.79 |
Market Cap
188M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.02
|
P/S
41.66
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-40.9K
|
FCF
-1.3
|
|
Op. Margin
-
|
Net Margin
-990.10%
|
ROE
599.70%
|
ROI
28.60%
|
|
ROA
-36.90%
|
EPS Growth
-61.90%
|
Current Ratio
0.9
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc (INM) | $0.27 | - | - | 1.6M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $15.72 | - | - | 1.19B | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
